"Miriam E. Tucker
Medscape Medical News
The U.S. Food and Drug Administration (FDA) will now require a "for single patient use only" warning on all multidose pen devices used for injectable diabetes medications.
Excess insulin administration may cause hypoglycemia and, particularly when given intravenously, hypokalemia. Mild episodes of hypoglycemia usually can be treated with oral glucose. Adjustments in drug dosage, meal patterns, or exercise may be needed. More severe episodes with coma, seizure, or neurologic impairment can be treated with intramuscular or subcutaneous glucagon or intravenous glucose. Sustained carbohydrate intake and observation may be necessary because hypoglycemia may recur after apparent clinical recovery. Hypokalemia must be corrected appropriately. [see WARNINGS AND PRECAUTIONS]
Novolin R is contraindicated:
- During episodes of hypoglycemia
- In patients with hypersensitivity to Novolin R or one of its excipients
Last reviewed on RxList: 4/5/2012
Additional Novolin R Information
Report Problems to the Food and Drug Administration
Find tips and advances in treatment.